Grey Cloak Tech (OTC: GRCK) this morning said that Eqova Live Sciences, the company’s acquisition target, exhibited at Denver’s Integrative Medicine Summit in Denver, Colorado, on October 7, 2017. Grey Cloak signed a Letter of Intent to acquire Eqova Life Sciences on September 19, 2017. Eqova Life Sciences develops clinical grade Full Spectrum Hemp Oil products that are sold exclusively through partnerships with licensed medical practitioners to use with their patients. Eqova debuted its new CannaBio Salve, an innovative topical salve with several aromatic natural oils, at the summit, which was attended by over 200 medical professionals. Eqova was the only company to exhibit CBD-based products. Upon the successful completion of due diligence and final acquisition agreements, Grey Cloak anticipates completing the acquisition of Eqova within the next 15 days.
To view the full press release, visit: http://cnw.fm/6J3bm
About Grey Cloak Tech Inc.
Grey Cloak develops advanced software to overcome the most costly digital threats. Sharing a vision for change and inspired to make the Internet a safer place, Grey Cloak’s founders began developing unique systems to eliminate online fraud and to ultimately build a secure internet for businesses and consumers, alike.Today, the company vigorously protects its clients’ interests by identifying fraud patterns at their earliest stages to eliminate fraud and its financial ramifications. The company has begun laying the foundation for the safe internet with its proprietary digital advertising fraud detection software, Fraudlytic. For more information, visit www.greycloaktech.com.
More from CannabisNewsBreaks
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
